...
首页> 外文期刊>International journal of clinical pharmacy. >Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients
【24h】

Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients

机译:对日本成年患者利奈唑胺诱发血小板减少症危险因素的回顾性分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Thrombocytopenia is a major side effect of linezolid therapy. However, there are few reports about the risk factors for linezolid-induced thrombocytopenia. Objective The aim of this study is to evaluate the risk factors for thrombocytopenia in patients who undergo linezolid therapy. Setting Aomori Prefectural Central Hospital in Japan, a tertiary 695 beds hospital. Method A retrospective review was performed using the hospital's medical records. From January 2010 to August 2012, 75 adult patients who received linezolid therapy were enrolled in this study. Main outcome measure Linezolid-induced thrombocytopenia was defined as a decrease in the patient's platelet count to <10 x 10~4/uL or a reduction of >30 % from their baseline value.
机译:背景血小板减少症是利奈唑胺治疗的主要副作用。然而,关于利奈唑胺诱导的血小板减少症的危险因素的报道很少。目的本研究旨在评估接受利奈唑胺治疗的患者血小板减少的危险因素。在日本青森县立中央医院设置三级病床695张。方法使用医院的病历进行回顾性审查。从2010年1月至2012年8月,本研究招募了75名接受利奈唑胺治疗的成年患者。主要预后指标利奈唑胺诱导的血小板减少症的定义为患者的血小板计数降低至<10 x 10〜4 / uL,或从基线值降低> 30%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号